 WES MOORE, Governor  Ch. 847  
 
– 1 – Chapter 847  
(House Bill 932 ) 
 
AN ACT concerning  
 
Health Insurance – Utilization Review – Revisions  
 
FOR the purpose of altering and establishing requirements and prohibitions related to 
health insurance utilization review; altering requirements related to internal 
grievance procedures and adverse decision procedures; altering certain reporting 
requirements on health insurance carriers relating to adverse decisions; establishing  
requirements on health insurance carriers and health care providers relating to the 
provision of patient benefit information; and generally relating to health insurance 
and utilization review.  
 
BY adding to  
 Article – Health – General  
Section 19 –108.5  
 Annotated Code of Maryland  
 (2023 Replacement Volume)  
 
BY repealing and reenacting, without amendments,  
 Article – Insurance  
 Section 15 –851 and 15 –10B–01(a)  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2023 Supplement)  
 
BY repealing and reena cting, with amendments,  
 Article – Insurance  
Section 15 –854 and 15 –10B–06 
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2023 Supplement)  
 (As enacted by Chapters 364 and 365 of the Acts of the General Assembly of 2023)  
 
BY adding to  
 Article – Insurance  
Section 15 –854.1  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2023 Supplement)  
 
BY repealing and reenacting, with amendments,  
 Article – Insurance  
Section 15 –10A–01, 15 –10A–02, 15 –10A–04(c), 15 –10A–06, 15 –10A–08,  
15–10B–01(b), 15–10B–02, 15 –10B–05, 15 –10B–07, and 15 –10B–09.1 
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2023 Supplement)  
Ch. 847  2024 LAWS OF MARYLAND   
 
– 2 –  
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Health – Gener al 
 
19–108.5.  
 
 (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 
INDICATED . 
 
  (2) “CARRIER” HAS THE MEANING STAT ED IN § 15–1301  OF THE 
INSURANCE ARTICLE . 
 
  (3) “HEALTH CARE PROVIDER ” HAS THE MEANING STAT ED IN §  
19–108.3  OF THIS SUBTITLE . 
 
 (B) (1) ON OR BEFORE JULY 1, 2026,  A CARRIER SHALL ESTA BLISH AND 
MAINTAIN AN ONLINE P ROCESS THAT : 
 
   (I) LINKS DIRECTLY TO ALL  E–PRESCRIBING SYSTEMS AND 
ELECTRONIC HEALTH RE CORD SYSTEMS THAT US E THE NATIONAL COUNCIL FOR 
PRESCRIPTION DRUG PROGRAMS SCRIPT  STANDARD AND THE NATIONAL 
COUNCIL FOR PRESCRIPTION DRUG PROGRAMS REAL TIME BENEFIT STANDARD ; 
 
   (II) CAN ACCEPT ELECTRONIC  PRIOR AUTHORIZATION 
REQUESTS FROM A HEAL TH CARE PROVIDER ; 
 
   (III) CAN APPROVE ELECTRONI C PRIOR AUTHORIZATIO N 
REQUESTS : 
 
    1. FOR WHICH NO ADDITIONAL INFORMATION IS 
NEEDED BY THE CARRIE R TO PROCESS THE PRI OR AUTHORIZATION REQ UEST ; 
 
    2. FOR WHICH NO CLINICAL  REVIEW IS REQUIRED ; AND 
 
    3. THAT MEET THE CARRIER ’S CRITERIA FOR 
APPROVAL ; AND 
 
   (IV) LINKS DIRECTLY TO REA L–TIME PATIE NT OUT–OF–POCKET 
COSTS , INCLUDING COPAYMENT , DEDUCTIBLE , AND COINSURANCE COST S, AND 
MORE AFFORDABLE MEDI CATION ALTERNATIVES MADE AVAILABLE BY TH E 
CARRIER . 
 
 WES MOORE, Governor  Ch. 847  
 
– 3 –   (2) A CARRIER MAY NOT : 
 
   (I) IMPOSE A FEE OR CHARG E ON A PERSON FOR AC CESSING 
THE ONLINE PROCESS  REQUIRED UNDER PARAG RAPH (1) OF THIS SUBSECTION ; OR 
 
   (II) ACCESS , WITHOUT HEALTH CARE PROVIDER CONSENT , 
HEALTH CARE PROVIDER  DATA VIA THE ONLINE PROCESS OTHER THAN F OR THE 
INSURED OR ENROLLEE . 
 
 (C) ON OR BEFORE JULY 1, 2025,  A CARRIER SHALL : 
 
  (1) ON REQUEST OF A HEALTH CARE PROVIDER , PROVIDE CONTACT 
INFORMATION FOR EACH  THIRD–PARTY VENDOR OR OTHE R ENTITY THAT THE 
CARRIER WILL USE TO MEET THE REQUIREMENT S OF SUBSECTION (B) OF THIS 
SECTION ; AND 
 
  (2) POST THE CONTACT INFO RMATION REQUIRED TO BE PROVIDE D 
UNDER ITEM (1) OF THIS SUBSECTION O N ITS WEBSITE . 
 
 (D) (1) ON OR BEFORE JULY 1, 2026,  EACH HEALTH CARE PRO VIDER 
SHALL ENSURE THAT EA CH E–PRESCRIBING SYSTEM O R ELECTRONIC HEALTH 
RECORD SYSTEM OWNED OR CONTRACTED FOR BY  THE HEALTH CARE PROV IDER TO 
MAINTAI N A HEALTH RECORD OF  AN INSURED OR ENROLL EE HAS THE ABILITY T O 
ACCESS , AT THE POINT OF PRES CRIBING : 
 
   (I) THE ELECTRONIC PRIOR AUTHORIZATION PROCES S 
ESTABLISHED BY A CAR RIER UNDER SUBSECTIO N (B) OF THIS SECTION ; AND 
 
   (II) THE REAL –TIME PATIENT OUT–OF–POCKET COST 
INFORMATION AND AVAI LABLE MEDICATION ALT ERNATIVES REQUIRED U NDER 
SUBSECTION (B) OF THIS SECTION . 
 
  (2) THE COMMISSION SHALL ESTA BLISH BY REGULATION A PROCESS 
THROUGH WHICH A HEAL TH CARE PROVIDER MAY  REQUEST AND RECEIVE A WAIVER 
OF COMPL IANCE FROM THE REQUI REMENTS OF THIS SUBS ECTION . 
 
 (E) (1) ON OR BEFORE JULY 1, 2026,  EACH CARRIER , OR A PHARMACY 
BENEFITS MANAGER ON BEHALF OF THE CARRIE R, SHALL : 
 
   (I) PROVIDE REAL –TIME PATIENT –SPECIFIC BENEFIT 
INFORMATION TO INSUR EDS AND ENROLLEES AN D CONTRACTED HEALTH CA RE 
PROVIDERS , INCLUDING ANY OUT –OF–POCKET COSTS AND MOR E AFFORDABLE 
MEDICATION ALTERNATI VES OR PRIOR AUTHORI ZATION REQUIREMENTS ; AND 
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 4 –    (II) ENSURE THAT THE INFOR MATION PROVIDED UNDE R ITEM 
(I) OF THIS PARAGRAPH IS  ACCURATE . 
 
  (2) EACH  CARRIER , OR A PHARMACY BENEFI TS MANAGER ON BEHALF  
OF THE CARRIER , SHALL MAKE AVAILABLE  THE INFORMATION REQU IRED TO BE 
PROVIDED UNDER PARAG RAPH (1) OF THIS SUBSECTION T O THE HEALTH CARE 
PROVIDER AT THE POIN T OF PRESCRIBING IN AN ACCESSIBLE AND 
UNDERSTANDAB LE FORMAT , SUCH AS THROUGH THE HEALTH CARE PROVIDER ’S  
E–PRESCRIBING SYSTEM O R ELECTRONIC HEALTH RECORD SYSTEM THAT T HE 
CARRIER , PHARMACY BENEFITS MA NAGER , OR DESIGNATED SUBCON TRACTOR HAS 
ADOPTED THAT USES TH E NATIONAL COUNCIL FOR PRESCRIPTION DRUG 
PROGRAM S SCRIPT  STANDARD AND THE NATIONAL COUNCIL FOR PRESCRIPTION 
DRUG PROGRAMS REAL TIME BENEFIT STANDARD FROM WHICH T HE HEALTH 
CARE PROVIDER MAKES THE REQUEST . 
 
Article – Insurance  
 
15–851. 
 
 (a) (1) This section applies to:  
 
   (i) insurers and nonprofit heal th service plans that provide coverage 
for substance use disorder benefits or prescription drugs under individual, group, or 
blanket health insurance policies or contracts that are issued or delivered in the State; and  
 
   (ii) health maintenance organizat ions that provide coverage for 
substance use disorder benefits or prescription drugs under individual or group contracts 
that are issued or delivered in the State.  
 
  (2) An insurer, a nonprofit health service plan, or a health maintenance 
organization tha t provides coverage for substance use disorder benefits under the medical 
benefit or for prescription drugs through a pharmacy benefits manager is subject to the 
requirements of this section.  
 
 (b) An entity subject to this section may not apply a prior au thorization 
requirement for a prescription drug:  
 
  (1) when used for treatment of an opioid use disorder; and  
 
  (2) that contains methadone, buprenorphine, or naltrexone.  
 
15–854. 
 
 (a) (1) This section applies to:  
 
 WES MOORE, Governor  Ch. 847  
 
– 5 –    (i) insurers and nonprofit health service plans that provide coverage 
for prescription drugs through a pharmacy benefit under individual, group, or blanket 
health insurance policies or contracts that are issued or delivered in the State; and  
 
   (ii) health maintenance organizations that p rovide coverage for 
prescription drugs through a pharmacy benefit under individual or group contracts that 
are issued or delivered in the State.  
 
  (2) An insurer, a nonprofit health service plan, or a health maintenance 
organization that provides coverage  for prescription drugs through a pharmacy benefits 
manager or that contracts with a private review agent under Subtitle 10B of this article is 
subject to the requirements of this section.  
 
  (3) This section does not apply to a managed care organization a s defined 
in § 15 –101 of the Health – General Article.  
 
 (b) (1) (i) If an entity subject to this section requires a prior authorization 
for a prescription drug, the prior authorization request shall allow a health care provider 
to indicate whether a presc ription drug is to be used to treat a chronic condition.  
 
   (ii) If a health care provider indicates that the prescription drug is 
to treat a chronic condition, an entity subject to this section may not request a 
reauthorization for a repeat prescription for the prescription drug for 1 year or for the 
standard course of treatment for the chronic condition being treated, whichever is less.  
 
  (2) For a prior authorization that is filed electronically, the entity shall 
maintain a database that will prepopulate prior authorization requests with an insured’s 
available insurance and demographic information.  
 
 (c) [If an entity subject to this section denies coverage for a prescription drug, the 
entity shall provide a detailed written explanation for the  denial of coverage, including 
whether the denial was based on a requirement for prior authorization.  
 
 (d)] (1) On receipt of information documenting a prior authorization from the 
insured or from the insured’s health care provider, an entity subject to t his section shall 
honor a prior authorization granted to an insured from a previous entity for at least the 
[initial 30 ] LESSER OF 90 days [of an insured’s prescription drug benefit coverage under 
the health benefit plan of the new entity ] OR THE LENGTH OF  THE COURSE OF 
TREATMENT . 
 
  (2) During the time period described in paragraph (1) of this subsection, an 
entity may perform its own review to grant a prior authorization for the prescription drug.  
 
 [(e)] (D) (1) An entity subject to this section shall ho nor a prior authorization 
issued by the entity for a prescription drug AND MAY NOT REQUIRE A HEALTH CARE 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 6 – PROVIDER TO SUBMIT A  REQUEST FOR ANOTHER PRIOR AUTHORIZATION FOR THE 
PRESCRIPTION DRUG : 
 
   (i) if the insured changes health benefit plans that are both covered 
by the same entity and the prescription drug is a covered benefit under the current health 
benefit plan; or  
 
   (ii) except as provided in paragraph (2) of this subsection, when the 
dosage for the approved prescription drug changes and the cha nge is consistent with federal 
Food and Drug Administration labeled dosages.  
 
  (2) [An] EXCEPT AS PROVIDED IN  § 15–851 OF THIS SUBTITLE , AN 
entity may [not be required to honor ] REQUIRE  a prior authorization for a change in dosage 
for an opioid under this  subsection.  
 
 [(f)] (E) (1) If an entity under this section implements a new prior 
authorization requirement for a prescription drug, the entity shall provide notice of the new 
requirement at least [30] 60 days before the implementation of a new prior aut horization 
requirement:  
 
  [(1)] (I) in writing to any insured who is prescribed the prescription drug; 
and 
 
  [(2)] (II) either in writing or electronically to all contracted health care 
providers.  
 
  (2) THE NOTICE REQUIRED U NDER PARAGRAPH (1) OF THIS 
SUBSECTION SHALL IND ICATE THAT THE INSUR ED MAY REMAIN ON THE  
PRESCRIPTION DRUG AT  THE TIME OF REAUTHOR IZATION IN ACCORDANC E WITH 
SUBSECTION (G) OF THIS SECTION . 
 
 [(g)] (F) (1) Except as provided in paragraph (2) of this subsection, an entity 
subject to th is section may not require more than one prior authorization if two or more 
tablets of different dosage strengths of the same prescription drug are:  
 
   (i) prescribed at the same time as part of an insured’s treatment 
plan; and  
 
   (ii) manufactured by th e same manufacturer.  
 
  (2) This subsection does not prohibit an entity from requiring more than 
one prior authorization if the prescription is for two or more tablets of different dosage 
strengths of an opioid that is not an opioid partial agonist.  
 
 WES MOORE, Governor  Ch. 847  
 
– 7 –  (G) (1) THIS SUBSECTION DOES NOT APPLY WITH RESPE CT TO A  
REAUTHORIZATION OF A  PRESCRIPTION DRUG RE QUESTED BY A PROVIDE R 
EMPLOYED BY A GROUP MODEL HEALTH MAINTEN ANCE ORGANIZATION , AS DEFINED  
IN § 19–713.6  OF THE HEALTH – GENERAL ARTICLE . 
 
  (2) AN ENTITY SUBJEC T TO THIS SECTION MA Y NOT ISSUE AN 
ADVERSE DECISION ON A REAUTHORIZATION FO R THE SAME PRESCRIPT ION DRUG 
OR REQUEST ADDITIONA L DOCUMENTATION FROM  THE PRESCRIBER FOR T HE 
REAUTHORIZATION REQU EST IF : 
 
   (I) THE PRESCRIPTION DRU G IS: 
 
    1. AN IMMUNE GLOBULIN  (HUMAN ) AS DEFINED IN 21 
C.F.R.  § 640.100;  OR 
 
    2. USED  FOR THE TREATMENT OF  A MENTAL DISORDER 
LISTED IN THE MOST R ECENT EDITION OF THE  DIAGNOSTIC AND STATISTICAL 
MANUAL OF MENTAL DISORDERS PUBLISHED B Y THE AMERICAN PSYCHIATRIC 
ASSOCIATION ;  
 
   (I) (II) THE ENTITY PREVIOUSL Y APPROVED A PRIOR 
AUTHORIZATION FOR TH E PRESCRIPTION DRUG FOR THE INSURED ; 
 
   (II) (III) THE INSURED HAS BEEN  TREATED WITH THE 
PRESCRIPTION DRUG WI THOUT INTERRUPTION S INCE THE INITIAL APP ROVAL OF 
THE PRIOR AUTHORIZAT ION; AND  
 
   (III) (IV) THE PRESCRIBER ATTES TS THAT , BASED ON THE 
PRESCRIBER ’S PROFESSIONAL JUDGM ENT, THE PRESCRIPTION DRU G CONTINUES 
TO BE NECESSARY TO E FFECTIVELY TREAT THE  INSURED ’S CONDITION . 
 
  (3) (2) IF THE PRESCRIPTION D RUG THAT IS BEING RE QUESTED HAS 
BEEN REMO VED FROM THE FORMULA RY OR HAS BEEN MOVED  TO A HIGHER 
DEDUCTIBLE , COPAYMENT , OR COINSURANCE TIER , THE ENTITY SHALL PRO VIDE  
THE INSURED AND INSU RED’S HEALTH CARE PROVID ER THE INFORMATION 
REQUIRED UNDER § 15–831 OF THIS SUBTITLE . 
 
15–854.1.  
 
 (A) (1) IN THIS SECTION THE FOLLOWIN G WORDS HAVE THE MEA NINGS 
INDICATED . 
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 8 –   (2) “ACTIVE COURSE OF TREA TMENT” MEANS A COURSE OF 
TREATMENT FOR WHICH AN INSURED IS ACTIVE LY SEEING A HEALTH C ARE 
PROVIDER AND FOLLOWI NG THE COURSE OF TRE ATMENT . 
 
  (3) “COURSE OF TREATMENT ” MEAN S TREATMENT THAT : 
 
   (I) IS PRESCRIBED TO TRE AT OR ORDERED FOR TH E 
TREATMENT OF AN INSU RED WITH A SPECIFIC CONDITION ; 
 
   (II) IS OUTLINED AND AGRE ED TO BY THE INSURED  AND THE 
HEALTH CARE PROVIDER  BEFORE THE TREATMENT  BEGINS ; AND 
 
   (III) MAY BE PART OF A TREATMENT PLAN . 
 
 (B) (1) THIS SECTION APPLIES TO: 
 
   (I) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 
PROVIDE HOSPITAL , MEDICAL , OR SURGICAL BENEFITS  TO INDIVIDUALS OR GR OUPS 
ON AN EXPENSE –INCURRED BASIS UNDER  HEALTH INSURANCE POL ICIES OR 
CONTRACTS  THAT ARE ISSUED OR D ELIVERED IN THE STATE ; AND 
 
   (II) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 
HOSPITAL , MEDICAL , OR SURGICAL BENEFITS  TO INDIVIDUALS OR GR OUPS UNDER 
CONTRACTS THAT ARE I SSUED OR DELIVERED I N THE STATE . 
 
  (2) AN INSURER , A NONPROFI T HEALTH SERVICE PLA N, OR A HEALTH 
MAINTENANCE ORGANIZA TION THAT CONTRACTS WITH A PRIVATE REVIE W AGENT 
UNDER SUBTITLE 10B  OF THIS TITLE IS SUB JECT TO THE REQUIREM ENTS OF THIS 
SECTION . 
 
  (3) AN INSURER , A NONPROFIT HEALTH S ERVICE PLAN , OR A HEALTH 
MAINTENA NCE ORGANIZATION THA T CONTRACTS WITH A T HIRD PARTY TO 
DISPENSE MEDICAL DEV ICES, MEDICAL APPLIANCES , OR MEDICAL GOODS FOR  THE 
TREATMENT OF A HUMAN  DISEASE OR DYSFUNCTI ON IS SUBJECT TO THE  
REQUIREMENTS OF THIS  SECTION . 
 
 (C) (1) NOTWITHSTANDING § 15–854 OF T HIS SUBTITLE AS IT A PPLIES TO 
COVERAGE FOR PRESCRI PTION DRUGS , AN ENTITY SUBJECT TO  THIS SECTION 
SHALL APPROVE A REQU EST FOR THE PRIOR AU THORIZATION OF A COU RSE OF 
TREATMENT , INCLUDING FOR CHRONI C CONDITIONS , REHABILITATIVE SERVI CES, 
SUBSTANCE USE DISORD ERS, AND MENTAL HEALTH CO NDITIONS , THAT IS : 
 
 WES MOORE, Governor  Ch. 847  
 
– 9 –    (I) FOR A PERIOD OF TIME  THAT IS AS LONG AS N ECESSARY TO 
AVOID DISRUPTIONS IN  CARE ; AND 
 
   (II) DETERMINED IN ACCORD ANCE WITH APPLICABLE  
COVERAGE CRITERIA , THE INSURED ’S MEDICAL HISTORY , AND THE HEALTH CARE 
PROVIDER’S RECOMMENDATION . 
 
  (2) FOR NEW ENROLLEES , AN ENTITY SUBJECT TO  THIS SECTION MAY 
NOT DISRUPT OR REQUI RE REAUTHORIZATION F OR AN ACTIVE COURSE OF 
TREATMENT FOR COVERED SERVICES  FOR AT LEAST 90 DAYS AFTER THE DATE OF 
ENROLLMENT . 
 
15–10A–01. 
 
 (a) In this subtitle the following words have the meanings indicated.  
 
 (b) (1) “Adverse decision” means:  
 
   (i) a utilization review determination by a private review agent, a 
carrier, or a health care provider acting on behalf of a carrier that:  
 
    1. a prop osed or delivered health care service covered under 
the member’s contract is or was not medically necessary, appropriate, or efficient; and  
 
    2. may result in noncoverage of the health care service; or  
 
   (ii) a denial by a carrier of a request by a member for an alternative 
standard or a waiver of a standard to satisfy the requirements of a wellness program under 
§ 15–509 of this title.  
 
  (2) “ADVERSE DECISION ” INCLUDES A UTILIZATI ON REVIEW 
DETERMINATION BASED ON A PRIOR AUTHORIZA TION OR STEP THERAP Y 
REQUIREMENT . 
 
  [(2)] (3) “Adverse decision” does not include a decision concerning a 
subscriber’s status as a member.  
 
 (c) “Carrier” means a person that offers a health benefit plan and is:  
 
  (1) an authorized insurer that provides health insurance in  the State;  
 
  (2) a nonprofit health service plan;  
 
  (3) a health maintenance organization;  
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 10 –   (4) a dental plan organization;  
 
  (5) a self –funded student health plan operated by an independent 
institution of higher education, as defined in § 10 –101 of the Education Article, that 
provides health care to its students and their dependents; or  
 
  (6) except for a managed care organization as defined in Title 15, Subtitle 
1 of the Health – General Article, any other person that provides health benefit plans 
subject to regulation by the State.  
 
 (d) “Complaint” means a protest filed with the Commissioner involving an 
adverse decision or grievance decision concerning the member.  
 
 (e) “Designee of the Commissioner” means any person to whom the Commissioner 
has delegated the authority to review and decide complaints filed under this subtitle, 
including an administrative law judge to whom the authority to conduct a hearing has been 
delegated for recommended or final decision.  
 
 (f) “Grievance” means a protest filed by a member, a member’s representative, or 
a health care provider on behalf of a member with a carrier through the carrier’s internal 
grievance process regarding an adverse decision concerning the member.  
 
 (g) “Grievance decision” means a final dete rmination by a carrier that arises from 
a grievance filed with the carrier under its internal grievance process regarding an adverse 
decision concerning a member.  
 
 (h) “Health Advocacy Unit” means the Health Education and Advocacy Unit in 
the Division of Consumer Protection of the Office of the Attorney General established under 
Title 13, Subtitle 4A of the Commercial Law Article.  
 
 (i) “Health benefit plan” has the meaning stated in § 2 –112.2(a) of this article.  
 
 (j) “Health care provider” means:  
 
  (1) an individual who is licensed under the Health Occupations Article to 
provide health care services in the ordinary course of business or practice of a profession 
and is a treating provider of the member; or  
 
  (2) a hospital, as defined in § 19 –301 of the Health – General Article.  
 
 (k) “Health care service” means a health or medical care procedure or service 
rendered by a health care provider that:  
 
  (1) provides testing, diagnosis, or treatment of a human disease or 
dysfunction; [or] 
 
 WES MOORE, Governor  Ch. 847  
 
– 11 –   (2) dispenses dru gs, medical devices, medical appliances, or medical goods 
for the treatment of a human disease or dysfunction ; OR 
 
  (3) PROVIDES ANY OTHER C ARE, SERVICE , OR TREATMENT OF 
DISEASE OR INJURY , THE CORRECTION OF DE FECTS , OR THE MAINTENANCE O F 
PHYSICAL OR MENTA L WELL–BEING OF INDIVIDUALS . 
 
 (l) (1) “Member” means a person entitled to health care benefits under a 
policy, plan, or certificate issued or delivered in the State by a carrier.  
 
  (2) “Member” includes:  
 
   (i) a subscriber; and  
 
   (ii) unless preempted by federal law, a Medicare recipient.  
 
  (3) “Member” does not include a Medicaid recipient.  
 
 (m) “Member’s representative” means an individual who has been authorized by 
the member to file a grievance or a complaint on the member’s behalf.  
 
 (n) “Private review agent” has the meaning stated in § 15 –10B–01 of this title.  
 
15–10A–02. 
 
 (a) Each carrier shall establish an internal grievance process for its members.  
 
 (b) (1) An internal grievance process shall meet the same requirements 
established  under Subtitle 10B of this title.  
 
  (2) In addition to the requirements of Subtitle 10B of this title, an internal 
grievance process established by a carrier under this section shall:  
 
   (i) include an expedited procedure for use in an emergency case fo r 
purposes of rendering a grievance decision within 24 hours of the date a grievance is filed 
with the carrier;  
 
   (ii) provide that a carrier render a final decision in writing on a 
grievance within 30 working days after the date on which the grievance i s filed unless:  
 
    1. the grievance involves an emergency case under item (i) of 
this paragraph;  
 
    2. the member, the member’s representative, or a health care 
provider filing a grievance on behalf of a member agrees in writing to an extension for a 
period of no longer than 30 working days; or  
Ch. 847  2024 LAWS OF MARYLAND   
 
– 12 –  
    3. the grievance involves a retrospective denial under item 
(iv) of this paragraph;  
 
   (iii) allow a grievance to be filed on behalf of a member by a health 
care provider or the member’s representative;  
 
   (iv) provide that a carrier render a final decision in writing on a 
grievance within 45 working days after the date on which the grievance is filed when the 
grievance involves a retrospective denial; and  
 
   (v) for a retrospective denial, allow a member,  the member’s 
representative, or a health care provider on behalf of a member to file a grievance for at 
least 180 days after the member receives an adverse decision.  
 
  (3) For purposes of using the expedited procedure for an emergency case 
that a carrier  is required to include under paragraph (2)(i) of this subsection, the 
[Commissioner shall define by regulation the standards required for a grievance to be 
considered an emergency case ] CARRIER SHALL INITIA TE THE EXPEDITED PRO CEDURE 
FOR AN EMERGENCY CAS E IF THE MEMBER OR THE ME MBER’S REPRESENTATIVE 
REQUESTS THE EXPEDIT ED REVIEW OR  THE HEALTH CARE PROV IDER OR THE 
MEMBER OR THE MEMBER ’S REPRESENTATIVE  ATTESTS THAT : 
 
   (I) THE ADVERSE DECISION  WAS RENDERED FOR HEA LTH CARE 
SERVICES THAT ARE PR OPOSED BUT HAVE NOT BEEN PROVIDED ; AND 
 
   (II) THE SERVICES ARE NEC ESSARY TO TREAT A CO NDITION OR 
ILLNESS THAT , WITHOUT IMMEDIATE ME DICAL ATTENTION , WOULD : 
 
    1. SERIOUSLY JEOPARDIZE  THE LIFE OR HEALTH O F THE 
MEMBER OR THE MEMBER ’S ABILITY TO REGAIN MAXIMUM FUNCTIONS ; 
 
    2. CAUSE THE MEMBER TO BE IN DANGER TO SELF  OR 
OTHERS ; OR 
 
    3. CAUSE THE MEMBER TO CONTINUE USING 
INTOXICATING SUBSTAN CES IN AN IMMINENTLY  DANGEROUS MANNER . 
 
 (c) Except as provided in subsection (d) of this section, the carrier’s internal 
grievanc e process shall be exhausted prior to filing a complaint with the Commissioner 
under this subtitle.  
 
 (d) (1) (i) A member, the member’s representative, or a health care 
provider filing a complaint on behalf of a member may file a complaint with the 
 WES MOORE, Governor  Ch. 847  
 
– 13 – Commis sioner without first filing a grievance with a carrier and receiving a final decision 
on the grievance if:  
 
    1. the carrier waives the requirement that the carrier’s 
internal grievance process be exhausted before filing a complaint with the Commissioner;  
 
    2. the carrier has failed to comply with any of the 
requirements of the internal grievance process as described in this section; or  
 
    3. the member, the member’s representative, or the health 
care provider provides sufficient informat ion and supporting documentation in the 
complaint that demonstrates a compelling reason to do so.  
 
   (ii) The Commissioner shall define by regulation the standards that 
the Commissioner shall use to decide what demonstrates a compelling reason under 
subparagraph (i) of this paragraph.  
 
  (2) Subject to subsections (b)(2)(ii) and (h) of this section, a member, a 
member’s representative, or a health care provider may file a complaint with the 
Commissioner if the member, the member’s representative, or t he health care provider does 
not receive a grievance decision from the carrier on or before the 30th working day on which 
the grievance is filed.  
 
  (3) Whenever the Commissioner receives a complaint under paragraph (1) 
or (2) of this subsection, the Commi ssioner shall notify the carrier that is the subject of the 
complaint within 5 working days after the date the complaint is filed with the 
Commissioner.  
 
 (e) Each carrier shall:  
 
  (1) file for review with the Commissioner and submit to the Health 
Advocac y Unit a copy of its internal grievance process established under this subtitle; and  
 
  (2) file any revision to the internal grievance process with the 
Commissioner and the Health Advocacy Unit at least 30 days before its intended use.  
 
 (f) (1) For nonem ergency cases, when a carrier renders an adverse decision, 
the carrier shall:  
 
  [(1)] (I) inform the member, the member’s representative, or the health 
care provider acting on behalf of the member of the adverse decision:  
 
   [(i)] 1. orally by telephone;  or 
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 14 –    [(ii)] 2. with the affirmative consent of the member, the member’s 
representative, or the health care provider acting on behalf of the member, by text, 
facsimile, e –mail, an online portal, or other expedited means; and  
 
  [(2)] (II) send, within 5 working days after the adverse decision has been 
made, a written notice to the member, the member’s representative, and a health care 
provider acting on behalf of the member that:  
 
   [(i)] 1. states in detail in clear, understandable language the 
specific  factual bases for the carrier’s decision  AND THE REASONING US ED TO 
DETERMINE THAT THE H EALTH CARE SERVICE I S NOT MEDICALLY NECE SSARY AND 
DID NOT MEET THE CAR RIER’S CRITERIA AND STAND ARDS USED IN CONDUCT ING 
THE UTILIZATION REVI EW; 
 
   [(ii)] 2. [references ] PROVIDES  the specific REFERENCE , 
LANGUAGE , OR REQUIREMENTS FROM  THE criteria and standards, including ANY 
interpretive guidelines, on which the decision was based, and may not solely use : 
 
    A. generalized terms such as “experimental procedure not 
covered”, “cosmetic procedure not covered”, “service included under another procedure”, or 
“not medically necessary” ; OR 
 
    B. LANGUAGE DIRECTING T HE MEMBER TO REVIEW THE 
ADDITIONAL COVERAGE CRITERIA IN THE MEMB ER’S POLICY OR PLAN DOC UMENTS ; 
 
   [(iii)] 3. states the name, business address, and business telephone 
number of:  
 
    [1.] A. IF THE CARRIER IS A HEALTH MAINTENANCE 
ORGANIZATION , the medical director or associate medical director, as appropriate, who 
made the decision [if the carrier is a health maintenance organization ]; or 
 
    [2.] B. IF THE CARRIER IS NO T A HEALTH 
MAINTENANCE ORGANIZA TION , the designated employee or representative of the carrier 
who has responsibility for the carrier’s internal grievance process [if the carrier is not a 
health  maintenance organization ] AND THE PHYSICIAN WH O IS REQUIRED TO MAK E 
ALL ADVERSE DECISION S AS REQUIRED IN § 15–10B–07(A) OF THIS TITLE ; 
 
   [(iv)] 4. gives written details of the carrier’s internal grievance 
process and procedures under this subtitle; and  
 
   [(v)] 5. includes the following information:  
 
 WES MOORE, Governor  Ch. 847  
 
– 15 –     [1.] A. that the member, the member’s representative, or a 
health care provider on behalf of the member has a right to file a complaint with the 
Commissioner within 4 months after receipt of a carrier’s  grievance decision;  
 
    [2.] B. that a complaint may be filed without first filing a 
grievance if the member, the member’s representative, or a health care provider filing a 
grievance on behalf of the member can demonstrate a compelling reason to do so a s 
determined by the Commissioner;  
 
    [3.] C. the Commissioner’s address, telephone number, 
and facsimile number;  
 
    [4.] D. a statement that the Health Advocacy Unit is 
available to assist the member or the member’s representative in both mediating and  filing 
a grievance under the carrier’s internal grievance process; and  
 
    [5.] E. the address, telephone number, facsimile number, 
and electronic mail address of the Health Advocacy Unit.  
 
  (2) THE BUSINESS TELEPHON E NUMBER INCLUDED IN  THE NOTICE AS 
REQUIRED UNDER PARAGRA PH (1)(II)3 OF THIS SUBSECTION M UST BE A DEDICATED 
NUMBER FOR ADVERSE D ECISIONS AND MAY NOT  BE THE GENERAL CUSTO MER CALL 
NUMBER FOR THE CARRI ER. 
 
 (g) If within 5 working days after a member, the member’s representative, or a 
health car e provider, who has filed a grievance on behalf of a member, files a grievance 
with the carrier, and if the carrier does not have sufficient information to complete its 
internal grievance process, the carrier shall:  
 
  (1) AFTER CONFIRMING THR OUGH A COMPLETE REVIEW OF A NY 
INFORMATION ALREADY SUBMITTED BY THE HEA LTH CARE PROVIDER : 
 
   (I) notify the member, the member’s representative, or the health 
care provider that it cannot proceed with reviewing the grievance unless additional 
information is provi ded; 
 
   (II) REQUEST THE SPECIFIC  INFORMATION , INCLUDING ANY 
LAB OR DIAGNOSTIC TE ST OR OTHER MEDICAL INFORMATION THAT MUS T BE 
SUBMITTED TO COMPLET E THE INTERNAL GRIEV ANCE PROCESS ; AND 
 
   (III) PROVIDE THE SPECIFIC  REFERENCE , LANGUAGE , OR 
REQUIREMENTS FRO M THE CRITERIA AND S TANDARDS USED BY THE  CARRIER TO 
SUPPORT THE NEED FOR  THE ADDITIONAL INFOR MATION ; and  
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 16 –   (2) assist the member, the member’s representative, or the health care 
provider in gathering the necessary information without further delay.  
 
 (h) A carrier may extend the 30 –day or 45 –day period required for making a final 
grievance decision under subsection (b)(2)(ii) of this section with the written consent of the 
member, the member’s representative, or the health care provider who filed the griev ance 
on behalf of the member.  
 
 (i) (1) For nonemergency cases, when a carrier renders a grievance decision, 
the carrier shall:  
 
   (i) document the grievance decision in writing after the carrier has 
provided oral communication of the decision to the memb er, the member’s representative, 
or the health care provider acting on behalf of the member; and  
 
   (ii) send, within 5 working days after the grievance decision has been 
made, a written notice to the member, the member’s representative, and a health care  
provider acting on behalf of the member that:  
 
    1. states in detail in clear, understandable language the 
specific factual bases for the carrier’s decision AND THE REASONING US ED TO 
DETERMINE THAT THE H EALTH CARE SERVICE I S NOT MEDICALLY NECE SSARY AND 
DID NOT MEET THE CAR RIER’S CRITERIA AND STAND ARDS USED IN CONDUCT ING 
UTILIZATION REVIEW ; 
 
    2. [references ] PROVIDES  the specific REFERENCE , 
LANGUAGE , OR REQUIREMENTS FROM  THE criteria and standards, including ANY 
interpretive guidelines USED BY THE CARR IER, on which the grievance decision was 
based;  
 
    3. states the name, business address, and business telephone 
number of:  
 
    A. IF THE CARRIER IS A HEALTH MAINTENANCE 
ORGANIZATION , the medical director or associate medical director, as appropriate, wh o 
made the grievance decision; or  
 
    B. IF THE CARRIER IS NO T A HEALTH MAINTENAN CE 
ORGANIZATION , the designated employee or representative of the carrier who has 
responsibility for the carrier’s internal grievance process [if the carrier is not a health 
maintenance organization ] AND THE DESIGNATED E MPLOYEE OR REPRESENT ATIVE’S 
TITLE AND CLINICAL S PECIALTY ; and  
 
    4. includes the following information:  
 
 WES MOORE, Governor  Ch. 847  
 
– 17 –     A. that the member or the member’s representative has a 
right to file a complaint with the Commissi oner within 4 months after receipt of a carrier’s 
grievance decision;  
 
    B. the Commissioner’s address, telephone number, and 
facsimile number;  
 
    C. a statement that the Health Advocacy Unit is available to 
assist the member or the member’s representa tive in filing a complaint with the 
Commissioner; and  
 
    D. the address, telephone number, facsimile number, and 
electronic mail address of the Health Advocacy Unit.  
 
  (2) THE BUSINESS TELEPHON E NUMBER INCLUDED IN  THE NOTICE AS 
REQUIRED UNDER PARAG RAPH (1)(II)3 OF THIS SUBSECTION M UST BE A DEDICATED 
NUMBER FOR GRIEVANCE  DECISIONS AND MAY NO T BE THE GENERAL CUS TOMER 
CALL NUMBER FOR THE CARRIER . 
 
  [(2)] (3) [A] TO SATISFY THE REQUIR EMENTS OF THIS SUBSE CTION , 
A carrier may not use solely in [a] THE WRITTEN  notice sent under paragraph (1) of this 
subsection : 
 
   (I) generalized terms such as “experimental procedure not covered”, 
“cosmetic procedure not covered”, “service included under another procedure”, or “not 
medically necessary” [to satisfy the requirem ents of this subsection ]; OR 
 
   (II) LANGUAGE DIRECTING T HE MEMBER TO REVIEW THE 
ADDITIONAL COVERAGE CRITERIA IN THE MEMB ER’S POLICY OR PLAN DOC UMENTS . 
 
 (j) (1) For an emergency case under subsection (b)(2)(i) of this section, within 
1 day after a decisi on has been orally communicated to the member, the member’s 
representative, or the health care provider, the carrier shall send notice in writing of any 
adverse decision or grievance decision to:  
 
   (i) the member and the member’s representative, if any; and 
 
   (ii) if the grievance was filed on behalf of the member under 
subsection (b)(2)(iii) of this section, the health care provider.  
 
  (2) A notice required to be sent under paragraph (1) of this subsection shall 
include the following:  
 
   (i) for an adverse decision, the information required under 
subsection (f) of this section; and  
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 18 –    (ii) for a grievance decision, the information required under 
subsection (i) of this section.  
 
 (k) (1) Each carrier shall include the information required by subsecti on 
[(f)(2)(iii), (iv), and (v) ] (F)(1)( II)3, 4, AND 5 of this section in the policy, plan, certificate, 
enrollment materials, or other evidence of coverage that the carrier provides to a member 
at the time of the member’s initial coverage or renewal of cov erage.  
 
  (2) Each carrier shall include as part of the information required by 
paragraph (1) of this subsection a statement indicating that, when filing a complaint with 
the Commissioner, the member or the member’s representative will be required to 
autho rize the release of any medical records of the member that may be required to be 
reviewed for the purpose of reaching a decision on the complaint.  
 
 (l) (1) Nothing in this subtitle prohibits a carrier from delegating its internal 
grievance process to a pr ivate review agent that has a certificate issued under Subtitle 10B 
of this title and is acting on behalf of the carrier.  
 
  (2) If a carrier delegates its internal grievance process to a private review 
agent, the carrier shall be:  
 
   (i) bound by the gri evance decision made by the private review 
agent acting on behalf of the carrier; and  
 
   (ii) responsible for a violation of any provision of this subtitle 
regardless of the delegation made by the carrier under paragraph (1) of this subsection.  
 
15–10A–04. 
 
 (c) (1) It is a violation of this subtitle for a carrier to fail to fulfill the carrier’s 
obligations to provide or reimburse for health care services specified in the carrier’s policies 
or contracts with members.  
 
  (2) If, in rendering an adverse dec ision or grievance decision, a carrier fails 
to fulfill the carrier’s obligations to provide or reimburse for health care services specified 
in the carrier’s policies or contracts with members, the Commissioner may:  
 
   (i) issue an administrative order th at requires the carrier to:  
 
    1. cease inappropriate conduct or practices by the carrier or 
any of the personnel employed or associated with the carrier;  
 
    2. fulfill the carrier’s contractual obligations;  
 
    3. provide a health care service or payment that has been 
denied improperly; or  
 WES MOORE, Governor  Ch. 847  
 
– 19 –  
    4. take appropriate steps to restore the carrier’s ability to 
provide a health care service or payment that is provided under a contract; or  
 
   (ii) impose any penalty or fine or take any action as authorized:  
 
    1. for an insurer, nonprofit health service plan, or dental 
plan organization, under this article; or  
 
    2. for a health maintenance organization, under the Health 
– General Article or under this article.  
 
  (3) In addition to paragraph (1) of this subsection, it is a violation of this 
subtitle, if the Commissioner, in consultation with an independent review organization, 
medical expert, the Department, or other appropriate entity, determines that the criteria 
and standards used by a heal th maintenance organization to conduct utilization review are 
not[: 
 
   (i) objective;  
 
   (ii) clinically valid;  
 
   (iii) compatible with established principles of health care; or  
 
   (iv) flexible enough to allow deviations from norms when justified on 
a case by case basis ] IN ACCORDANCE WITH § 15–10B–06 § 15–10B–05 OF THIS TITLE . 
 
15–10A–06. 
 
 (a) On [a quarterly ] AN ANNUAL  basis, each carrier shall submit to the 
Commissioner, on the form the Commissioner requires, a report that describes:  
 
  (1) the activities of the carrier under this subtitle, including:  
 
   (i) the outcome of each grievance filed with the carrier;  
 
   (ii) the number and outcomes of cases that were considered 
emergency cases under § 15 –10A–02(b)(2)(i) of this subtitle;  
 
   (iii) the time within which the carrier made a grievance decision on 
each emergency case;  
 
   (iv) the time within which the carrier made a grievance decision on 
all other cases that were not considered emergency cases;  
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 20 –    (v) the number of grievances filed wit h the carrier that resulted from 
an adverse decision involving length of stay for inpatient hospitalization as related to the 
medical procedure involved; [and] 
 
   (vi) the number of adverse decisions issued by the carrier under §  
15–10A–02(f) of this sub title, THE TYPE OF UTILIZAT ION REVIEW PROCESS U SED, IF 
APPLICABLE , WHETHER THE ADVERSE DECISION INVOLVED A PRIOR 
AUTHORIZATION OR STE P THERAPY PROTOCOL , and the type of service at issue in the 
adverse decisions; [and] 
 
   (VII) THE TIME WITHIN WHIC H THE CARRIER MADE THE ADV ERSE  
DECISIONS UNDER EACH  TYPE OF SERVICE AT I SSUE IN THE ADVERSE DECISIONS ; 
 
   (VIII) (VII) THE NUMBER OF ADVERS E DECISIONS OVERTURN ED 
AFTER A RECONSIDERAT ION REQUEST UNDER § 15–10B–06 OF THIS TITLE ; AND  
 
   (IX) (VIII) THE NUMBER OF REQUESTS MADE AND GR ANTED 
UNDER § 15–831( C)(1)  AND (2) OF THIS TITLE ; AND  
 
  (2) the number and outcome of all other cases that are not subject to 
activities of the carrier under this subtitle that resulted from an adverse decision involving 
the length of stay for inpatient hospitalization as related to the medical procedure involved.  
 
 (b) The Commissioner shall:  
 
  (1) compile an annual summary report based on the information provided:  
 
   (i) under subsection (a) of this section; and  
 
   (ii) by the Secretary under § 19 –705.2(e) of the Health – General 
Article; [and] 
 
  (2) REPORT ANY VIOLATION S OR ACTIONS TAKEN U NDER §  
15–10B–11 OF THIS TITLE ; AND  
 
  [(2)] (3) provide copies of the summary report to the Governor and, 
subject to § 2 –1257 of the State Government Article, to the General Assembly.  
 
15–10A–08. 
 
 (a) On or before November 1, 1999, and each November 1 thereafter, the Health 
Advocacy Unit shall publish an annual summary report and provide copies of the report to 
the Governor and, su bject to § 2 –1257 of the State Government Article, the General 
Assembly.  
 
 WES MOORE, Governor  Ch. 847  
 
– 21 –  (b) (1) The annual summary report required under subsection (a) of this 
section shall be on the grievances and complaints filed with or referred to a carrier, the 
Commissioner, the Health Advocacy Unit, or any other federal or State government agency 
or unit under this subtitle during the previous fiscal year.  
 
  (2) In consultation with the Commissioner and any affected State 
government agency or unit, the Health Advocacy Unit shall : 
 
   (i) evaluate the effectiveness of the internal grievance process and 
complaint process available to members; and  
 
   (ii) include in the annual summary report the results of the 
evaluation and any proposed changes TO THE LAW that it considers necessa ry TO ENSURE 
COMPLIANCE WITH THE PURPOSES OF THE LAW . 
 
15–10B–01. 
 
 (a) In this subtitle the following words have the meanings indicated.  
 
 (b) (1) “Adverse decision” means a utilization review determination made by a 
private review agent that a proposed o r delivered health care service:  
 
   (i) is or was not medically necessary, appropriate, or efficient; and  
 
   (ii) may result in noncoverage of the health care service.  
 
  (2) “ADVERSE DECISION ” INCLUDES A UTILIZATI ON REVIEW 
DETERMINATION BASED ON A PRIOR  AUTHORIZATION OR STE P THERAPY 
REQUIREMENT . 
 
  [(2)] (3) “Adverse decision” does not include a decision concerning a 
subscriber’s status as a member.  
 
15–10B–02. 
 
 The purpose of this subtitle is to:  
 
  (1) promote the delivery of quality health care in a cost effective manner 
THAT ENSURES TIMELY ACCESS TO HEALTH CAR E SERVICES ; 
 
  (2) foster greater coordination , COMMUNICATION , AND TRANSPARENCY  
between payors , PATIENTS , and providers conducting utilization review activities;  
 
  (3) protect patients, business, and providers by ensuring that private 
review agents are qualified to perform utilization review activities and to make informed 
decisions on the appropriateness of medical care; and  
Ch. 847  2024 LAWS OF MARYLAND   
 
– 22 –  
  (4) ensure that private review agents maintain the confident iality of 
medical records in accordance with applicable State and federal laws.  
 
15–10B–05. 
 
 (a) In conjunction with the application, the private review agent shall submit 
information that the Commissioner requires including:  
 
  (1) a utilization review p lan that includes:  
 
   (i) the specific criteria and standards to be used in conducting 
utilization review of proposed or delivered health care services;  
 
   (ii) those circumstances, if any, under which utilization review may 
be delegated to a hospital ut ilization review program; and  
 
   (iii) if applicable, any provisions by which patients , OR physicians, or 
hospitals , OR OTHER HEALTH CARE  PROVIDERS  may seek reconsideration;  
 
  (2) the type and qualifications of the personnel either employed or under 
contract to perform the utilization review;  
 
  (3) a copy of the private review agent’s internal grievance process if a 
carrier delegates its internal grievance process to the private review agent in accordance 
with § 15 –10A–02(l) of this title;  
 
  (4) the procedures and policies to ensure that a representative of the 
private review agent is reasonably accessible to patients and health care providers 7 days 
a week, 24 hours a day in this State;  
 
  (5) if applicable, the procedures and policies to ensure tha t a representative 
of the private review agent is accessible to health care providers to make all determinations 
on whether to authorize or certify an emergency inpatient admission, or an admission for 
residential crisis services as defined in § 15 –840 of this title, for the treatment of a mental, 
emotional, or substance abuse disorder within 2 hours after receipt of the information 
necessary to make the determination;  
 
  (6) the policies and procedures to ensure that all applicable State and 
federal laws t o protect the confidentiality of individual medical records are followed;  
 
  (7) a copy of the materials designed to inform applicable patients and 
providers of the requirements of the utilization review plan;  
 
  (8) a list of the third party payors for wh ich the private review agent is 
performing utilization review in this State;  
 WES MOORE, Governor  Ch. 847  
 
– 23 –  
  (9) the policies and procedures to ensure that the private review agent has 
a formal program for the orientation and training of the personnel either employed or under 
contract  to perform the utilization review;  
 
  (10) a list of the persons involved in establishing the specific criteria and 
standards to be used in conducting utilization review , INCLUDING EACH PERSO N’S 
BOARD CERTIFICATION OR PRACTICE SPECIALT Y, LICENSURE CATEGOR Y, AND 
TITLE WITHIN THE PER SON’S ORGANIZATION ; and  
 
  (11) certification by the private review agent that the criteria and standards 
to be used in conducting utilization review are GENERALLY RECOGNIZED  BY HEALTH 
CARE PROVIDERS PRACT ICING IN THE RELEVAN T CL INICAL SPECIALTIES A ND ARE : 
 
   (i) objective;  
 
   (ii) clinically valid;  
 
   [(iii) compatible with established principles of health care; and  
 
   (iv) flexible enough to allow deviations from norms when justified on 
a case by case basis ] 
 
   (III) REFLECTED IN PUBLISHED  PEER–REVIEWED SCIENTIFIC 
STUDIES AND MEDICAL LITERATURE ; 
 
   (IV) DEVELOPED BY : 
 
    1. A NONPROFIT HEALTH C ARE PROVIDER 
PROFESSIONAL MEDICAL  OR CLINICAL SPECIALT Y SOCIETY , INCLUDING THROUGH 
THE USE OF PATIENT P LACEMENT CRITERIA AN D CLINICAL PRACTICE GU IDELINES ; 
OR 
 
    2. FOR CRITERIA NOT WIT HIN THE SCOPE OF A 
NONPROFIT HEALTH CAR E PROVIDER PROFESSIO NAL MEDICAL OR CLINI CAL 
SPECIALTY SOCIETY , AN ORGANIZATION THAT  WORKS DIRECTLY WITH HEALTH 
CARE PROVIDERS IN TH E SAME SPECIALTY FOR  THE DESIGNATED CRITERIA WHO 
ARE EMPLOYED OR ENGA GED WITHIN THE ORGAN IZATION OR OUTSIDE T HE 
ORGANIZATION TO DEVE LOP THE CLINICAL CRI TERIA , IF THE ORGANIZATION : 
 
    A. DOES NOT RECEIVE DIR ECT PAYMENTS BASED O N THE 
OUTCOME OF THE UTILI ZATION REVIEW ; AND 
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 24 –     B. DEMONSTRATES THAT IT S CLINICAL CRITERIA ARE 
CONSISTENT WITH CRIT ERIA AND STANDARDS G ENERALLY RECOGNIZED BY HEALTH 
CARE PROVIDERS PRACT ICING IN THE RELEVAN T CLINICAL SPECIALTI ES; 
 
   (V) RECOMMENDED BY FEDER AL AGENCIES ; 
 
   (VI) APPROVED BY THE FEDE RAL FOOD  AND DRUG 
ADMINISTRATION AS PAR T OF DRUG LABELING ; 
 
   (VII) TAKING INTO ACCOUNT THE NEEDS OF ATYPICA L PATIENT 
POPULATIONS AND DIAG NOSES , INCLUDING THE UNIQUE  NEEDS OF CHILDREN AN D 
ADOLESCENTS ; 
 
   (VIII) SUFFICIENTLY FLEXIBL E TO ALLOW DEVIATION S FROM 
NORMS WHEN JUSTIFIED  ON A CASE –BY–CASE BASIS , INCLUDING THE NEED T O USE 
AN OFF–LABEL PRESCRIPTION D RUG; 
 
   (IX) ENSURING QUALITY OF CARE OF HEALTH CARE SERVICES ; 
 
   (X) REVIEWED , EVALUATED , AND UPDATED AT LEAST  
ANNUALLY AND AS NECE SSARY TO REFLECT ANY  CHANGES ; AND 
 
   (XI) IN COMPLIANCE WITH A NY OTHER CRITERIA AN D 
STANDARDS REQUIRED F OR COVERAGE UNDER TH IS TITLE , INCLUDING 
COMPLIANCE WITH § 15–802( D) OF THIS TITLE FOR TH E TREATMENT OF SUBST ANCE 
USE DISORDERS . 
 
 (b) [On the written request of any person or  health care facility, the ] THE private 
review agent shall [provide 1 copy of ]: 
 
  (1) POST ON ITS WEBSITE OR THE CARRIER ’S WEBSITE the specific 
criteria and standards to be used in conducting utilization review of proposed or delivered 
services and any su bsequent revisions, modifications, or additions to the specific criteria 
and standards to be used in conducting utilization review of proposed or delivered services 
[to the person or health care facility making the request ]; AND  
 
  (2) ON THE REQUEST OF A PERSON , INCLUDING A HEALTH C ARE 
FACILITY , PROVIDE A COPY OF TH E INFORMATION SPECIF IED UNDER ITEM (1) OF 
THIS SUBSECTION TO T HE PERSON MAKING THE  REQUEST . 
 
 (c) The private review agent may charge a reasonable fee for a HARD copy of the 
specific criteria an d standards or any subsequent revisions, modifications, or additions to 
the specific criteria to any person or health care facility requesting a copy under subsection 
[(b)] (B)(2) of this section.  
 WES MOORE, Governor  Ch. 847  
 
– 25 –  
 (d) A private review agent shall advise the Commissioner,  in writing, of a change 
in: 
 
  (1) ownership, medical director, or chief executive officer within 30 days of 
the date of the change;  
 
  (2) the name, address, or telephone number of the private review agent 
within 30 days of the date of the change; or  
 
  (3) the private review agent’s scope of responsibility under a contract.  
 
15–10B–06. 
 
 (a) (1) Except as OTHERWISE provided in [paragraph (4) of ] this subsection, 
a private review agent shall:  
 
   (i) make all initial determinations on whether to authorize or certify 
a nonemergency course of treatment OR HEALTH CARE SERVI CE, INCLUDING 
PHARMACEUTICAL SERVI CES NOT SUBMITTED EL ECTRONICALLY , for a patient within 
2 working days after receipt of the informati on necessary to make the determination;  
 
   (ii) make all determinations on whether to authorize or certify an 
extended stay in a health care facility or additional health care services within 1 working 
day after receipt of the information necessary to mak e the determination; [and] 
 
   (III) MAKE ALL DETERMINATI ONS TO AUTHORIZE OR CERTIFY A 
REQUEST FOR ADDITION AL VISITS OR DAYS OF  CARE SUBMITTED AS PA RT OF AN 
EXISTING COURSE OF T REATMENT OR TREATMEN T PLAN WITHIN 1 WORKING DAY 
AFTER RECEIPT OF THE  INFORMATIO N NECESSARY TO MAKE THE DETERMINATION ; 
AND 
 
   [(iii)] (IV) promptly notify the health care provider of the 
determination.  
 
  (2) [If within 3 calendar days after ] AFTER  receipt of the initial request 
for health care services AND CONFIRMING THROU GH A COMPLETE REVIEW  OF 
INFORMATION ALREADY SUBMITTED BY THE HEA LTH CARE PROVIDER , IF the private 
review agent DETERMINES THAT THE PRIVATE REVIEW AGENT  does not have sufficient 
information to make a determination, the private review age nt shall PROMPTLY , BUT NOT 
LATER THAN 3 CALENDAR DAYS AFTER RECEIPT OF THE INITI AL REQUEST , inform 
the health care provider that additional information must be provided BY SPECIFYING : 
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 26 –    (I) THE INFORMATION , INCLUDING ANY LAB OR  DIAGNOSTIC 
TEST OR OTHER M EDICAL INFORMATION , THAT MUST BE SUBMITT ED TO COMPLETE 
THE REQUEST ; AND 
 
   (II) THE CRITERIA AND STA NDARDS TO SUPPORT TH E NEED FOR 
ADDITIONAL INFORMATI ON. 
 
  [(3)] (B) If a private review agent requires prior authorization for an 
emergency inpatient admission, or an admission for residential crisis services as defined in 
§ 15–840 of this title, for the treatment of a mental, emotional, or substance abuse disorder, 
the private review agent shall:  
 
   [(i)] (1) make all determinations on whether to auth orize or certify 
an inpatient admission, or an admission for residential crisis services as defined in §  
15–840 of this title, within 2 hours after receipt of the information necessary to make the 
determination; [and] 
 
  (2) IF ADDITIONAL INFORM ATION IS N EEDED , PROMPTLY REQUEST 
THE SPECIFIC INFORMA TION NEEDED , INCLUDING ANY LAB OR  DIAGNOSTIC TEST OR 
OTHER MEDICAL INFORM ATION ; AND 
 
   [(ii)] (3) promptly notify the health care provider of the 
determination.  
 
  [(4)] (C) (1) For a step therapy exception requ est submitted 
electronically in accordance with a process established under § 15 –142(f) of this title or a 
prior authorization request submitted electronically for pharmaceutical services, a private 
review agent shall make a determination:  
 
   (i) in real time if:  
 
    1. no additional information is needed by the private review 
agent to process the request; and  
 
    2. the request meets the private review agent’s criteria for 
approval; or  
 
   (ii) if a request is not approved IN REAL TIME under item (i) of  this 
paragraph, within 1 [business ] WORKING  day after the private review agent receives all of 
the information necessary to make the determination.  
 
  (2) IF ADDITIONAL INFORMA TION IS NEEDED TO MA KE A 
DETERMINATION AFTER CONFIRMING THROUGH A  COMPLETE REVIEW OF T HE 
INFORMATION ALREADY SUBMITTED BY THE HEA LTH CARE PROVIDER , THE PRIVATE 
 WES MOORE, Governor  Ch. 847  
 
– 27 – REVIEW AGENT SHALL R EQUEST THE INFORMATI ON PROMPTLY , BUT NOT LATER 
THAN 3 CALENDAR DAYS AFTER R ECEIPT OF THE INITIA L REQUEST , BY SPECIFYING : 
 
   (I) THE INFORMATION , INCLUDING ANY LAB OR  DIAGNOSTIC 
TEST OR OTHER MEDICA L INFORMATION , THAT MUST BE SUBMITT ED TO COMPLETE 
THE REQUEST ; AND 
 
   (II) THE CRITERIA AND STA NDARDS TO SUPPORT  THE NEED FOR 
THE ADDITIONAL INFOR MATION . 
 
 (D) (1) (I) A EXCEPT AS PROVIDED IN  SUBSECTIONS (G) AND (H) OF 
THIS SECTION , A PRIVATE REVIEW AGENT  SHALL MAKE INITIAL D ETERMINATIONS 
ON WHETHER TO AUTHOR IZE OR CERTIFY AN EM ERGENCY COURSE OF TR EATMENT 
OR HEALTH CARE SERVICE FOR A M EMBER WITHIN 24 HOURS AFTER THE INIT IAL 
REQUEST AFTER RECEIP T OF THE INFORMATION  NECESSARY TO MAKE TH E 
DETERMINATION . 
 
   (II) IF THE PRIVATE REVIEW  AGENT DETERMINES THA T 
ADDITIONAL INFORMATI ON IS NEEDED AFTER C ONFIRMING THROUGH A COMPL ETE 
REVIEW OF THE INFORM ATION ALREADY SUBMIT TED BY THE HEALTH CA RE 
PROVIDER , THE PRIVATE REVIEW A GENT SHALL : 
 
    1. PROMPTLY REQUEST THE  SPECIFIC INFORMATION  
NEEDED , INCLUDING ANY LAB OR  DIAGNOSTIC TEST OR O THER MEDICAL 
INFORMATION ; AND 
 
    2. PROMPTLY , BUT NOT LATER THAN 2 HOURS AFTER 
RECEIPT OF THE INFOR MATION , NOTIFY THE HEALTH CA RE PROVIDER OF AN 
AUTHORIZATION OR CER TIFICATION DETERMINA TION WHEN MADE BY TH E PRIVATE 
REVIEW AGENT . 
 
  (2) A PRIVATE REVIEW AGENT  SHALL INITIATE THE E XPEDITED 
PROCEDURE FOR AN EMERGENCY CASE IF  THE PATIENT OR THE P ATIENT’S 
REPRESENTATIVE REQUE STS OR IF  THE HEALTH CARE PROV IDER ATTESTS THAT 
THE SERVICES ARE NEC ESSARY TO TREAT A CO NDITION OR ILLNESS T HAT, WITHOUT 
IMMEDIATE MEDICAL AT TENTION , WOULD : 
 
   (I) SERIOUSLY JEOPARDIZE  THE LIFE OR HEALTH O F THE 
MEMBER OR THE MEMBER ’S ABILITY TO REGAIN MAXIMUM FUNCTIONS ; 
 
   (II) CAUSE THE MEMBER TO BE IN DANGER TO SELF  OR OTHERS ; 
OR 
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 28 –    (III) CAUSE THE MEMBER TO CONTINUE USING INTOX ICATING 
SUBSTANCES IN AN IMM INENTLY DANGEROUS MA NNER . 
 
 (E) IF A PRIVATE REVIEW A GENT FAILS TO MAKE A  DETERMINATION WITHIN  
THE TIME LIMITS REQU IRED UNDER THIS SECT ION, THE REQUEST SHALL BE  
DEEMED APPROVED . 
 
 [(b)] (F) (1) If an initial determination is made by a private review agent not 
to authorize or certify a health care service and the health care provider believes the 
determination warrants an immediate reconsideration, a private review agent [may] 
SHALL  provide the health care provider the opportunity to speak with the physician that 
rendered the determina tion, by telephone on an expedited basis, within a period of time not 
to exceed 24 hours of the health care provider seeking the reconsideration.  
 
  (2) IF THE PHYSICIAN IS U NABLE TO IMMEDIATELY  SPEAK WITH THE 
HEALTH CARE PROVIDER  SEEKING THE RECONSID ERATI ON, THE PHYSICIAN SHALL 
PROVIDE THE HEALTH C ARE PROVIDER WITH TH E FOLLOWING CONTACT 
INFORMATION FOR THE HEALTH CARE PROVIDER  TO USE TO CONTACT TH E 
PHYSICIAN : 
 
   (I) A DIRECT TELEPHONE N UMBER THAT IS NOT TH E GENERAL 
CUSTOMER CALL NUMBER ; OR 
 
   (II) A MONITORED E –MAIL ADDRESS THAT IS  DEDICATED TO 
COMMUNICATION RELATE D TO UTILIZATION REV IEW. 
 
 [(c)] (G) For emergency inpatient admissions, a private review agent may not 
render an adverse decision solely because the hospital did not notify the private revi ew 
agent of the emergency admission within 24 hours or other prescribed period of time after 
that admission if the patient’s medical condition prevented the hospital from determining:  
 
  (1) the patient’s insurance status; and  
 
  (2) if applicable, the pri vate review agent’s emergency admission 
notification requirements.  
 
 [(d)] (H) (1) Subject to paragraph (2) of this subsection, a private review 
agent may not render an adverse decision as to an admission of a patient during the first 
24 hours after admiss ion when:  
 
   (i) the admission is based on a determination that the patient is in 
imminent danger to self or others;  
 
 WES MOORE, Governor  Ch. 847  
 
– 29 –    (ii) the determination has been made by the patient’s physician or 
psychologist in conjunction with a member of the medical staff of t he facility who has 
privileges to make the admission; and  
 
   (iii) the hospital immediately notifies the private review agent of:  
 
    1. the admission of the patient; and  
 
    2. the reasons for the admission.  
 
  (2) A private review agent may not render  an adverse decision as to an 
admission of a patient to a hospital for up to 72 hours, as determined to be medically 
necessary by the patient’s treating physician, when:  
 
   (i) the admission is an involuntary admission under §§ 10 –615 and 
10–617(a) of the  Health – General Article; and  
 
   (ii) the hospital immediately notifies the private review agent of:  
 
    1. the admission of the patient; and  
 
    2. the reasons for the admission.  
 
 [(e)] (I) (1) A private review agent that requires a health care provider to 
submit a treatment plan in order for the private review agent to conduct utilization review 
of proposed or delivered services for the treatment of a mental illness, emotional disorder, 
or a substance abuse disorder:  
 
   (i) shall accept:  
 
    1. the uniform treatment plan form adopted by the 
Commissioner under § 15 –10B–03(d) of this subtitle as a properly submitted treatment 
plan form; or  
 
    2. if a service was provided in another state, a treatment plan 
form mandated by the state in which the  service was provided; and  
 
   (ii) may not impose any requirement to:  
 
    1. modify the uniform treatment plan form or its content; or  
 
    2. submit additional treatment plan forms.  
 
  (2) A uniform treatment plan form submitted under the provisions of this 
subsection:  
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 30 –    (i) shall be properly completed by the health care provider; and  
 
   (ii) may be submitted by electronic transfer.  
 
15–10B–07. 
 
 (a) (1) Except as provided in paragraphs (2) and (3) of this subsection, all 
adverse decisions shall be made by a LICENSED physician, or a panel of other appropriate 
health care service reviewers with at least one physician on the panel , who is : 
 
   (I) board cert ified or eligible in the same specialty as the treatment 
under review ; AND  
 
   (II) KNOWLEDGEABLE ABOUT THE REQUESTED HEALTH  CARE 
SERVICE OR TREATMENT  THROUGH ACTUAL CLINI CAL EXPERIENCE . 
 
  (2) When the health care service under review is a mental health o r 
substance abuse service, the adverse decision shall be made by a LICENSED physician, or 
a panel of other appropriate health care service reviewers with at least one LICENSED  
physician, selected by the private review agent who:  
 
   (i) is board certified or eligible in the same specialty as the 
treatment under review; or  
 
   (ii) is actively practicing or has demonstrated expertise in the 
substance abuse or mental health service or treatment under review.  
 
  (3) When the health care service under review is  a dental service, the 
adverse decision shall be made by a licensed dentist, or a panel of other appropriate health 
care service reviewers with at least one licensed dentist on the panel WHO IS 
KNOWLEDGEABLE ABOUT THE REQUESTED HEALTH  CARE SERVICE OR TREA TMENT 
THROUGH ACTUAL CLINI CAL EXPERIENCE . 
 
 (b) All adverse decisions shall be made by a physician or a panel of other 
appropriate health care service reviewers who are not compensated by the private review 
agent in a manner that violates § 19 –705.1 of the Health – General Article or that deters 
the delivery of medically appropriate care.  
 
 (c) Except as provided in subsection (d) of this section, if a course of treatment 
has been preauthorized or approved for a patient, a private review agent may not 
retros pectively render an adverse decision regarding the preauthorized or approved 
services delivered to that patient.  
 
 (d) A private review agent may retrospectively render an adverse decision 
regarding preauthorized or approved services delivered to a patient  if: 
 WES MOORE, Governor  Ch. 847  
 
– 31 –  
  (1) the information submitted to the private review agent regarding the 
services to be delivered to the patient was fraudulent or intentionally misrepresentative;  
 
  (2) critical information requested by the private review agent regarding 
services to be delivered to the patient was omitted such that the private review agent’s 
determination would have been different had the agent known the critical information; or  
 
  (3) the planned course of treatment for the patient that was approved by 
the private  review agent was not substantially followed by the provider.  
 
 (e) If a course of treatment has been preauthorized or approved for a patient, a 
private review agent may not revise or modify the specific criteria or standards used for the 
utilization review to make an adverse decision regarding the services delivered to that 
patient.  
 
15–10B–09.1.  
 
 A grievance decision shall be made based on the professional judgment of:  
 
  (1) (i) a LICENSED physician who is board certified or eligible in the 
same sp ecialty as the treatment under review AND KNOWLEDGEABLE AB OUT THE 
REQUESTED HEALTH CAR E SERVICE OR TREATME NT THROUGH ACTUAL CL INICAL 
EXPERIENCE ; or 
 
   (ii) a panel of other appropriate health care service reviewers with 
at least one LICENSED physician on the panel who is board certified or eligible in the same 
specialty as the treatment under review AND KNOWLEDGEABLE AB OUT THE 
REQUESTED HEALTH CAR E SERVICE OR TREATME NT THROUGH ACTUAL CL INICAL 
EXPERIENCE ; 
 
  (2) when the grievance decision involves a dental  service, a licensed 
dentist, or a panel of appropriate health care service reviewers with at least one dentist on 
the panel who is a licensed dentist, who shall consult with a dentist who is board certified 
or eligible in the same specialty as the service  under review AND KNOWLEDGEABLE 
ABOUT THE REQUESTED HEALTH CARE SERVICE OR TREATMENT THROUGH  ACTUAL 
CLINICAL EXPERIENCE ; or 
 
  (3) when the grievance decision involves a mental health or substance 
abuse service:  
 
   (i) a licensed physician who:  
 
    1. is board certified or eligible in the same specialty as the 
treatment under review; or  
 
Ch. 847  2024 LAWS OF MARYLAND   
 
– 32 –     2. is actively practicing or has demonstrated expertise in the 
substance abuse or mental health service or treatment under review; or  
 
   (ii) a panel of other approp riate health care service reviewers with 
at least one LICENSED physician, selected by the private review agent who:  
 
    1. is board certified or eligible in the same specialty as the 
treatment under review; or  
 
    2. is actively practicing or has demonst rated expertise in the 
substance abuse or mental health service or treatment under review.  
 
 SECTION 2. AND BE IT FURTHER ENACTED, That:  
 
 (a) The Maryland Health Care Commission and the Maryland Insurance 
Administration, in consultation with health care practitioners and payors of health care 
services, jointly shall conduct a study on the development of standards for the 
implementation of payor programs to modify prior authorization requirements for 
prescription drugs, medical care, and other health care services based on health care 
practitioner –specific criteria.  
 
 (b) The study conducted under subsection (a) of this section shall include, through 
an examination of literature review and legislatively or voluntarily established programs 
that have been imp lemented or are being considered in other states, an analysis of:  
 
  (1) adjustments to payor prior authorization requirements based on a 
health care practitioner’s:  
 
   (i) prior approval rates;  
 
   (ii) ordering and prescribing patterns; and  
 
   (iii) participation in a payor’s two –sided incentive arrangement or a 
capitation program; and  
 
  (2) any other information or metrics necessary to implement the payor 
programs.  
 
 (c) On or before December 1, 2024, the Maryland Health Care Commission and 
the Maryla nd Insurance Administration jointly shall submit a report to the General 
Assembly, in accordance with § 2 –1257 of the State Government Article, with the findings 
and recommendations from the study, including recommendations for legislative initiatives 
necessary for the establishment of payor programs modifying prior authorization 
requirements based on health care practitioner –specific criteria.  
 
 SECTION 3. AND BE IT FURTHER ENACTED, That:  
 WES MOORE, Governor  Ch. 847  
 
– 33 –  
 (a) The Maryland Health Care Commission and the Maryland Insurance  
Administration jointly shall establish a workgroup to , in consultation with the Maryland 
Insurance Administration, shall : 
 
  (1) assess  monitor  the progress toward implementing the requirements in 
§ 19–108.5 of the Health – General Article, as enacted by Section 1 of this Act, including 
monitoring any federal or State developments relating to the requirements; and  
 
  (2) review issues or recommendations from other states that are 
implementing a real –time benefit requirement, including establishing a link a t the point of 
prescribing for any available coupons.  
 
 (b) On or before December 1, 2025, the Maryland Health Care Commission and 
the Maryland Insurance Administration jointly shall submit a report to  shall inform  the 
General Assembly, in accordance with § 2–1257 of the State Government Article, with  of 
any findings and recommendations from the workgroup  relating to the implementation of 
§ 19–108.5 of the Health – General Article, as enacted by Section 1 of this Act . 
 
 SECTION 4. AND BE IT FURTHER ENACTED,  That Section 1 of this Act shall take 
effect January 1, 2025.  
 
 SECTION 5. AND BE IT FURTHER ENACTED, That, except as provided in Section 
4 of this Act, this Act shall take effect July 1, 2024.  
 
Approved by the Governor, May 16, 2024.  